Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)
Clinical trial NCT01738360 · TERMINATED
Trial details
- NCT number
- NCT01738360
- Sponsor
- Nantes University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-10-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.